Asymmetric Short Duplex RNA with Interspersed Deoxyribonucleotides as a Gene Silencing Technology and Use Thereof
Assignee1Globe Health Institute LLC
InventorsChiang J. LI, Xiangao SUN, Charles LI
Life of this patent
Estimating the term…
Loading patent…
Assignee1Globe Health Institute LLC
InventorsChiang J. LI, Xiangao SUN, Charles LI
Estimating the term…
The present invention discloses a novel type of gene silencing technology for modulating target nucleic acid and/or protein levels in cells, tissues, organisms and animals. The new technology provides compositions for use in gene targeting or gene silencing applications, including prevention and treatment of human diseases. The composition comprises an asymmetric, short, duplex RNA molecule where the sense strand is shorter than the antisense strand. The duplex RNA molecule further includes at least one interspersed segment of deoxyribonucleotides monomers. The present invention further provides methods of using the compositions for modulating expression or function of a target gene, or for treatment or prevention of diseases as well as for other medical or biological applications.
An asymmetric short duplex RNA (asdRNA) molecule comprising a first strand and a second strand each comprising linked nucleotide monomers,
An asymmetric short duplex RNA (asdRNA) molecule comprising a first strand and a second strand each comprising linked ribonucleotide monomers with at least one interspersed segment of deoxyribonucleotide monomer(s) (ISD) disposed in the first strand,
Dependencies are inferred from the claim text.